Shows
Psy Diaries#007 Interview with Adam Deffett: less guns, more research lab coatsWe talk with Adam Deffett, CEO of Ketamine One, about their plans for psychedelic research, and how VR and wearables will play a role. Plus thoughts on the changing perspective of psychedelics & mental health.Highlights— THE NUGGET: Beckley Psytech's $80M raise (0:38)— THE NOODLE: time to triage the various psychedelic patients (1:07)— Why Ketamine One chose VR and wearables (2:26) — Why Adam left capital markets to go all-in on psychedelics (6:38)— Adam as the drug czar: less guns and more lab coats (13:31)— Surprise: the variety of opinions in psychedelic medicine (10:00)— SOUL SEARCH: a mystical experience with...2021-09-0328 min